The total amount of the transaction was worth $64,500, noted the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Boston Scientific is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties, including interventional cardiology, endoscopy, peripheral interventions and urology/women’s health, according to the report.
More articles on GI/endoscopy:
Global endoscopy market to reach $47B by 2020: 8 key trends
GI Dynamics names Michael Dale president & CEO
Diagnostic Endoscopy Center’s Dr. Stuart Waldstreicher honored
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
